ScholarLens Back to search
2007•Dalian Yike Daxue xuebaoRequires access

Expression of SICAM-1 in serum of hepatitis B patients

Jie Lü

Open publisher page 0 citations

Abstract

[Objective] To investigate expression of SICAM-1 in the serum of hepatitis B patients and its relation with diseases.[Methods] SICAM-1 level of 60 hepatitis B patients and 30 healthy control were detected by ELASA,in step detected ALT and AST level.[Results] SICAM-1 in hepatitis B patients whose transaminase increased(201.26 98.69)ng/mL were evidently higher than that in control(35.32±10.67)ng/mL and in hepatitis B patients whose transaminase were normal(36.32±10.67)ng/mL(P0.01),there was no difference between control groups(35.32±10.67)ng/mL and normal groups 36.32 10.67 ng/mL(P0.05).[Conclusion] SICAM-1's high level in hepatitis B patients with high transaminase suggests that SICAM takes part in the process of hepatitis episode and it is correlated with degree of the illness.SICAM can act as one of markers evaluating degree of liver injury in hepatitis B patients.

About this research paper

What this paper is about

[Objective] To investigate expression of SICAM-1 in the serum of hepatitis B patients and its relation with diseases.[Methods] SICAM-1 level of 60 hepatitis B patients and 30 healthy control were detected by ELASA,in step detected ALT and AST level.[Results] SICAM-1 in hepatitis B patients whose transaminase increased(201.26 98.69)ng/mL were evidently higher than that in control(35.32±10.67)ng/mL and in hepatitis B patients whose transaminase were normal(36.32±10.67)ng/mL(P0.01),there was no difference between control groups(35.32±10.67)ng/mL and normal groups 36.32 10.67 ng/mL(P0.05).[Conclusion] SICAM-1's high level in hepatitis B patients with high transaminase suggests that SICAM takes part in the process of hepatitis episode and it is correlated with degree of the illness.SICAM can act as one of markers evaluating degree of liver injury in hepatitis B patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To investigate expression of SICAM-1 in the serum of hepatitis B patients and its relation with diseases.[Methods] SICAM-1 level of 60 hepatitis B patients and 30 healthy control were detected by ELASA,in step detected ALT and AST level.[Results] SICAM-1 in hepatitis B patients whose transaminase increased(201.26 98.69)ng/mL were evidently higher than that in control(35.32±10.67)ng/mL and in hepatitis B patients whose transaminase were normal(36.32±10.67)ng/mL(P0.01),there was no difference between control groups(35.32±10.67)ng/mL and normal groups 36.32 10.67 ng/mL(P0.05).[Conclusion] SICAM-1's high level in hepatitis B patients with high transaminase suggests that SICAM takes part in the process of hepatitis episode and it is correlated with degree of the illness.SICAM can act as one of markers evaluating degree of liver injury in hepatitis B patients.

Key concepts: Transaminase, Medicine, Hepatitis, Hepatitis B, Internal medicine, Gastroenterology, Aspartate transaminase, Alanine transaminase

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Expression of SICAM-1 in serum of hepatitis B patients — Research Paper | ScholarLens